Empress Looks To The Body’s Internal Chemistry For Drug Leads

 
• By Joseph Haas

Emerging Company Profile: Backed by Flagship Pioneering, Empress deploys its Chemilogics platform to seek leads for small molecule therapies in inflammation, immunology, cancer and metabolic disease.

Emerge
Empress uses its Chemilogics platform for quick drug leads in multiple therapeutic areas • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs